NCT06143137View on ClinicalTrials.gov

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

RecruitingOBSERVATIONAL

Enrollment

142

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

February 28, 2030

Conditions

Severe Sepsis

Trial Locations (2)

39130

RECRUITING

Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin, Magdeburg

Unknown

RECRUITING

Universitätsmedizin Rostock, Abteilung KAI, Rostock

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

ZKS Jena

UNKNOWN

lead

Artcline GmbH

INDUSTRY

NCT06143137 - Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up | Biotech Hunter | Biotech Hunter